PDIA6 and lung adenocarcinoma: PDIA6 increased the resistance of lung adenocarcinoma cells to chemotherapeutic drugs through inhibition of apoptosis and autophagy of cancer cells [13], and inhibition of PDIA6 promoted the sensitivity of gastric cancer cells to cisplatin [14].